133 related articles for article (PubMed ID: 6121320)
1. [Pharmacology and clinical pharmacokinetics of nadolol].
Lazowski J; Wegrzyn B; Lypka A
Pol Tyg Lek; 1981 Sep; 36(39):1521-4. PubMed ID: 6121320
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of nadolol, a beta-receptor antagonist: administration of therapeutic single- and multiple-dosage regimens to hypertensive patients.
Dreyfuss J; Griffith DL; Singhvi SM; Shaw JM; Ross JJ; Vukovich RA; Willard DA
J Clin Pharmacol; 1979; 19(11-12):712-20. PubMed ID: 43870
[No Abstract] [Full Text] [Related]
3. Comment on the comment on nadolol article.
Drug Intell Clin Pharm; 1981; 15(7-8):603. PubMed ID: 6113946
[No Abstract] [Full Text] [Related]
4. Pharmacokinetics of betaxolol in middle aged patients.
Bianchetti G; Thiercelin JF; Thenot JP
Eur J Clin Pharmacol; 1986; 31(2):231-3. PubMed ID: 2879735
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenoceptor-blocking agents: pharmacokinetic differences and their clinical implications illustrated on pindolol.
Meier J
Cardiology; 1979; 64 Suppl 1():1-13. PubMed ID: 42483
[No Abstract] [Full Text] [Related]
6. Elimination of nadolol by patients with renal impairment.
Herrera J; Vukovich RA; Griffith DL
Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):227S-231S. PubMed ID: 37878
[TBL] [Abstract][Full Text] [Related]
7. [The pharmacokinetics of 1-(4-cyclohexylureidophenoxy)-2-hydroxy-3-tert-butylaminopropane (talinolol, Cordanum, 02-115) 2. Excretion, blood level and distribution of the 14C-labeled compound in the rat].
Klemm W; Wenzel A
Pharmazie; 1975 Oct; 30(10):675-7. PubMed ID: 695
[No Abstract] [Full Text] [Related]
8. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
Regårdh CG
Acta Pharmacol Toxicol (Copenh); 1975; 37(1):1-39. PubMed ID: 237402
[No Abstract] [Full Text] [Related]
9. [Clinical evaluation of the hypotensive effects of nadolol].
Hanzlik J; Sodolski W; Stelmasiak T; Wolański I
Kardiol Pol; 1982; 25(2):101-6. PubMed ID: 6125620
[No Abstract] [Full Text] [Related]
10. [Nadolol-induced adrenergic beta-block in the treatment of thyrotoxicosis (author's transl)].
Felt V; Nedvídková J
Cas Lek Cesk; 1982 Mar; 121(9):266-8. PubMed ID: 6121628
[No Abstract] [Full Text] [Related]
11. The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol.
Jack DB; Kendall MJ; Dean S; Laugher SJ; Zaman R; Tenneson ME
Biopharm Drug Dispos; 1982; 3(1):47-54. PubMed ID: 6123352
[TBL] [Abstract][Full Text] [Related]
12. Mediation of blood pressure by nadolol and alpha methyldopa.
Jenkins AC; Rosenthal J; Stumpe KO
Practitioner; 1981 Mar; 225(1353):405-9. PubMed ID: 6115378
[No Abstract] [Full Text] [Related]
13. [Clinical evaluation of nadolol in coronary disease].
Krotkiewski A; Zatorski A; Jarecki M; Ruszkowski J; Szelemetko J
Pol Tyg Lek; 1980 Jun; 35(22):833-6. PubMed ID: 6106925
[No Abstract] [Full Text] [Related]
14. Pharmacokinetics of nadolol in healthy subjects.
Schäfer-Korting M; Bach N; Knauf H; Mutschler E
Eur J Clin Pharmacol; 1984; 26(1):125-7. PubMed ID: 6714285
[TBL] [Abstract][Full Text] [Related]
15. [Use of nadolol in coronary disease].
Tkaczewski W; Goch JH; Dziekański S
Kardiol Pol; 1983; 26(3):215-9. PubMed ID: 6138456
[No Abstract] [Full Text] [Related]
16. Efficacy and safety of nadolol in angina pectoris.
Cruz J; Conceicao JM; Coelho EM
Practitioner; 1982 Aug; 226(1370):1452-3. PubMed ID: 6127670
[No Abstract] [Full Text] [Related]
17. [Effectiveness of the prolonged-action beta-blockader nadolol in the treatment of ischemic heart disease].
Kirichenko AA; Aslibekian IS; Ivanova LN; Zurabian KM
Klin Med (Mosk); 1985 Oct; 63(10):88-92. PubMed ID: 2867247
[No Abstract] [Full Text] [Related]
18. Nadolol in hypertensive patients maintained on long-term hemodialysis.
Michaels RS; Duchin KL; Akbar S; Meister J; Levin NW
Am Heart J; 1984 Oct; 108(4 Pt 2):1091-4. PubMed ID: 6148869
[TBL] [Abstract][Full Text] [Related]
19. Nadolol and antidepressant response.
Faber R
Biol Psychiatry; 1983 Nov; 18(11):1338-9. PubMed ID: 6140034
[No Abstract] [Full Text] [Related]
20. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
O'Callaghan EG
Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
[No Abstract] [Full Text] [Related]
[Next] [New Search]
